-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$46.0046.22% Upside
Akero Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Akero Therapeutics, Inc.?
Akero Therapeutics, Inc. has been rated by research analysts at H.C. Wainwright, Canaccord Genuity, Wolfe Research, Evercore ISI in the past 90 days.